Oncology-Based Molecular Diagnostic Market Anticipated to Reach 12.3 USD Billion, at a Notable 5.7% CAGR by 2035

WiseGuy Reports, Oct. 2025 (Press Release) – The Oncology-Based Molecular Diagnostic Market Global Outlook:

Global Oncology-Based Molecular Diagnostic Market Growth Analysis and Trends Report Technology (PCR Testing, Next-Generation Sequencing, In Situ Hybridization, Microarray Analysis), By Test Type (Genetic Testing, Epigenetic Testing, Circulating Tumor DNA Testing, Biomarker Testing), By Application (Cancer Detection, Cancer Prognosis, Cancer Treatment Selection, Monitoring Treatment Response), By End Use (Hospitals, Diagnostic Laboratories, Research Institutions) and By Regions - Global Industry Forecast 2025 to 2035

Oncology-Based Molecular Diagnostic Market Overview

Oncology-Based Molecular Diagnostic Market Set to Witness Remarkable Growth by 2035

The Oncology-Based Molecular Diagnostic Market is experiencing rapid growth, driven by increasing cancer prevalence, technological advancements, and rising demand for precision medicine. Valued at USD 6.73 billion in 2024, the market is expected to reach USD 7.11 billion in 2025 and expand to USD 12.3 billion by 2035, registering a CAGR of 5.7% over the forecast period. B2B stakeholders, including diagnostic laboratories, pharmaceutical companies, hospitals, and research institutions, are leveraging innovative molecular diagnostic solutions to enhance early detection, treatment personalization, and overall patient outcomes.

Molecular diagnostics in oncology are widely applied for early cancer detection, prognosis, treatment selection, and monitoring therapeutic response. Test types include PCR-based assays, next-generation sequencing (NGS), microarrays, and biomarker detection. Increasing biomarker research, expanding healthcare infrastructure, and the growing emphasis on personalized medicine are key drivers supporting market growth.

🔥 Get Your Sample Report Now!

https://www.wiseguyreports.com/sample-request?id=735897

Technological advancements in genomics, bioinformatics, and automated diagnostic platforms are improving accuracy, sensitivity, and turnaround time. Companies are developing high-throughput, cost-effective, and clinically validated solutions to address diverse oncology applications. Expansion of partnerships between diagnostic firms and pharmaceutical companies is further enhancing market adoption and creating revenue opportunities.

Regional Insights

North America dominates the Oncology-Based Molecular Diagnostic Market, driven by advanced healthcare infrastructure, high adoption of innovative diagnostics, and strong R&D capabilities. The U.S. is a major contributor, with extensive implementation of molecular testing and strong regulatory support. Europe holds a significant market share, fueled by reimbursement policies, awareness programs, and growing investment in cancer diagnostics.

APAC is emerging as a high-growth region due to increasing cancer incidence, expanding healthcare facilities, and growing awareness about molecular diagnostics. Countries such as China, India, Japan, and South Korea are witnessing rapid adoption of advanced diagnostic technologies. South America and MEA show steady growth, supported by healthcare investments, government initiatives, and collaborations with international diagnostic solution providers.

👉 Purchase Report Here

https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=735897

Market Segmentation

The Oncology-Based Molecular Diagnostic Market is segmented to provide actionable insights:

• Technology: PCR, next-generation sequencing (NGS), microarrays, biomarker detection, and other molecular techniques.
• Test Type: Companion diagnostics, predictive diagnostics, prognostic assays, and monitoring tests.
• Application: Breast cancer, lung cancer, colorectal cancer, hematologic cancers, and others.
• End Use: Hospitals, diagnostic laboratories, research institutions, and specialty clinics.
• Regional Analysis: North America, Europe, APAC, South America, and MEA.

Competitive Landscape

Key companies profiled in the Oncology-Based Molecular Diagnostic Market include BioMerieux, Illumina, Hologic, Thermo Fisher Scientific, Guardant Health, Roche, Agilent Technologies, Abbott Laboratories, Qiagen, Dako, Exact Sciences, Sysmex Corporation, Myriad Genetics, NeoGenomics Laboratories, and F. Hoffmann-La Roche. These companies focus on innovation, strategic partnerships, product development, and global expansion to strengthen market presence and address the rising demand for molecular diagnostics in oncology.

📄 Full Report Link

https://www.wiseguyreports.com/reports/oncology-based-molecular-diagnostic-market

Market Opportunities

Opportunities in the Oncology-Based Molecular Diagnostic Market are significant. Growth in personalized medicine, adoption of advanced genomic technologies, increasing prevalence of cancer, and rising demand for early diagnosis are expected to drive market expansion. Companies investing in integrated diagnostic platforms, high-throughput testing, and collaborations with pharma are well-positioned to capitalize on these opportunities.

Reasons To Buy The Oncology-Based Molecular Diagnostic Market Report:

➼ In-depth analysis of the Oncology-Based Molecular Diagnostic Market on the global and regional levels.

➼ Major changes in market dynamics and competitive landscape.

➼ Segmentation on the basis of type, application, geography, and others.

➼ Historical and future market research in terms of size, share growth, volume, and sales.

➼ Major changes and assessment in market dynamics and developments.

➼ Emerging key segments and regions

➼ Key business strategies by major market players and their key methods

Other Related Reports from Latest WiseGuy Reports:

  Farm Animals Medicines and Vaccines Market

Flocked Swab Market

Food Allergy Therapeutics Market

ESD Knife Market

Experimental Animals Market

Epidural Flat Filter Market

ERG Test Device Market

Factor XIII Concentrate Market

Gastric Carcinoma Drugs Market

Fertility Test Rapid Kit Market

About US:

Wise Guy Reports is pleased to introduce itself as a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. We want our clients to have information that can be used to act upon their strategic initiatives. We, therefore, aim to be your trustworthy partner within dynamic business settings through excellence and innovation. By offering comprehensive market intelligence, our company enables corporate organizations to make informed choices, drive growth, and stay ahead in competitive markets